Mitomycin C (Teva) Inj 5 mg and 20 mg vial: Hospital supply issue resolved

Mitomycin C inj 5 mg vial

Affected product

PCT only- Specialist

• Presentation: Inj 5 mg vial
• Brand: Teva
• Pharmacode: 2137844
• Subsidy: $641.70
• Measure / Qty: per 1

This presentation is listed 'any brand' in the HML.

Alternatives listed 

Like the Accord product, these brands are not Medsafe approved and need to be prescribed and dispensed in line with section 29 of the Medicines Act.

• Brand: Mitomycin Sagent
• Pharmacode: 2686937
• Pack size: 1
• Subsidy: $526.00
• Available to order through Link

• Brand: Mitomycin Fresenius Kabi
• Pharmacode: 2677016
• Pack size: 1
• Subsidy: $577.50
• Available to order through CDC

Mitomycin C inj 20 mg vial

Affected product

PCT only- Specialist

• Presentation: Inj 20 mg vial
• Brand: Teva
• Pharmacode: 2601761
• Subsidy: $1250.00
• Measure / Qty: per 1

Alternative listed 

Teva has sourced a supply of Omegapharma mitomycin C, which will be supplied under Section 29 until the Teva brand is back in stock. Teva has supplied the Omegapharma brand before, but registration has now lapsed.

This stock will have Australian packaging.

• Presentation: Inj 20 mg vial
• Brand: Omegapharm
• Unapproved medicine supplied under Section 29.
• Pharmacode: 2580160 
• Subsidy: $1250.00
• Measure / Qty: per 1

Information about Omegapharm mitomycin C on the Australian Medicinewise website(external link)

Resupplied early December 2024

Teva (the supplier) advises that stock is available from the first week of December 2024. It may take another 1 to 2 weeks for stock to reach pharmacies around the motu. 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)